STEP Pharma is a biotechnology company focused on developing targeted cancer therapies, particularly through the inhibition of CTPS1
STEP Pharma is a biotechnology company focused on developing targeted cancer therapies, particularly through the inhibition of CTPS1. Their lead asset, dencatistat, is in clinical development for various cancers and blood disorders.